4444565
doi
10.5281/zenodo.4444565
oai:zenodo.org:4444565
STUDYING NATURE, RISK STRATIFICATION AND DRUGS IMPACT ON ARRHYTHMOGENIC RIGHT CARDIOMYOPATHY
Dr Nashwah Javaid, Dr Muhammad Munib Ur Rehman,Dr Waqar Afzal.
info:eu-repo/semantics/openAccess
Creative Commons Attribution 4.0 International
https://creativecommons.org/licenses/by/4.0/legalcode
<p><em>Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a form of cardiomyopathy that mostly occurs in young seemingly healthy individuals and athletes, causing sudden cardiac death and ventricular tachyarrhythmias [1]. The illness is described by limited or diffuse decay of prevalently right ventricular myocardium with resulting substitution by greasy and stringy tissue [2,3]. These underlying irregularities are principally situated in the surge plot, summit, and sub tricuspid zone of the privilege ventricular free divider [4].</em></p>
Zenodo
2021-01-16
info:eu-repo/semantics/article
4444564
1610800042.82013
552628
md5:64c4762c6b75f4bb6f80e078844ddacd
https://zenodo.org/records/4444565/files/320.T-Studying Nature, Risk Stratification and Drugs impact on Arrhythmogenic Right Cardiomyopathy.pdf
public
10.5281/zenodo.4444564
isVersionOf
doi